Gerber Kawasaki Wealth & Investment Management Raises Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Gerber Kawasaki Wealth & Investment Management raised its position in UnitedHealth Group Incorporated (NYSE:UNH) by 2.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,176 shares of the healthcare conglomerate’s stock after purchasing an additional 26 shares during the period. Gerber Kawasaki Wealth & Investment Management’s holdings in UnitedHealth Group were worth $595,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in UNH. Norges Bank purchased a new position in shares of UnitedHealth Group during the fourth quarter worth about $6,375,744,000. Raymond James Financial Inc. bought a new position in shares of UnitedHealth Group in the 4th quarter worth $1,914,740,000. Amundi lifted its holdings in shares of UnitedHealth Group by 97.2% during the 4th quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate’s stock worth $3,183,132,000 after acquiring an additional 2,991,470 shares during the last quarter. Proficio Capital Partners LLC increased its stake in UnitedHealth Group by 76,830.4% in the fourth quarter. Proficio Capital Partners LLC now owns 1,888,641 shares of the healthcare conglomerate’s stock valued at $955,388,000 after acquiring an additional 1,886,186 shares during the last quarter. Finally, Capital International Investors lifted its stake in UnitedHealth Group by 6.2% during the fourth quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate’s stock worth $7,899,905,000 after purchasing an additional 906,365 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 1.4 %

UNH opened at $418.20 on Friday. The stock has a market cap of $380.66 billion, a PE ratio of 26.98, a PEG ratio of 1.37 and a beta of 0.61. The business has a 50 day moving average of $503.28 and a 200-day moving average of $534.62. UnitedHealth Group Incorporated has a 52 week low of $412.02 and a 52 week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $109.58 billion during the quarter, compared to analysts’ expectations of $111.56 billion. During the same period in the prior year, the company earned $6.91 earnings per share. Equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 2.01%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s payout ratio is 35.18%.

Analyst Upgrades and Downgrades

UNH has been the topic of a number of research reports. Cantor Fitzgerald reissued an “overweight” rating and set a $700.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. Morgan Stanley cut their price objective on shares of UnitedHealth Group from $664.00 to $563.00 and set an “overweight” rating for the company in a research note on Tuesday, April 22nd. Royal Bank of Canada cut their price target on shares of UnitedHealth Group from $655.00 to $525.00 and set an “outperform” rating for the company in a research report on Wednesday. Erste Group Bank upgraded UnitedHealth Group to a “strong-buy” rating in a research report on Wednesday, April 16th. Finally, Barclays cut their target price on shares of UnitedHealth Group from $642.00 to $560.00 and set an “overweight” rating on the stock in a report on Monday, April 21st. Three equities research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and three have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $603.05.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.